Event Program
19 March 2025
Focus: Stakeholder perspectives on AFR
Chair: Prof Paul Verweij, Radboud University Medical Centre, Nijmegen, The Netherlands
10:30
Young ISHAM pre-meeting
Program TBCDr Jochem Buil, Dr Auke de Jong
12:30
Registration
Coffee, tea, sandwiches
13:30
Introduction
Objectives of ABR2AFRProf Paul Verweij
13:45
Deliverables ABR2AFR: consensus declaration and road map
Dr Maarten van Dongen, AMR Insights, The Netherlands
Dr Maarten van Dongen, AMR Insights, The Netherlands
14:00
Outcome AFR Surveillance study
TBC (INFORM-AMR)
TBC (INFORM-AMR)
14:15
LMIC perspective on AFR
TBC
TBC
14:30
coffee, tea
15:00
Stakeholder Perspectives
EU perspectiveTBC (EU)
15:15
EPA perspective
TBC (EPA)
TBC (EPA)
15:30
WHO perspective
TBC (WHO)
TBC (WHO)
15:45
Producers perspective
TBC (Producers)
TBC (Producers)
16:00
Agri (users) perspective
TBC (Agri)
TBC (Agri)
16:15
Regulatory perspective
TBC (CTGB)
TBC (CTGB)
16:30
Clinical (users) perspective
TBC (Clinical)
TBC (Clinical)
16:45
Patient perspective
TBC (Patients)
TBC (Patients)
17:00
Pharma perspective
TBC (Pharma)
TBC (Pharma)
17:15
Regulatory (EMA) perspective
TBC (EMA)
TBC (EMA)
17:30
Wrap up day 1
Prof Paul Verweij
Prof Paul Verweij
17:45
Informal get together
Drinks, street food
19:00
Closure day 1
20 March 2025
Focus: Translating ABR into AFR
Chair: Dr Maarten van Dongen, AMR Insights BV, The Netherlands
08:30
Coffee, tea
09:00
Antibiotic resistance (ABR)
Global and national action plansTBC (WHO / Quadripartite Secretariat)
09:15
Antibiotics dual use challenges
TBC (idem)
TBC (idem)
09:30
Introductions 6 ABR Focal Areas
TBC
TBC
09:45
Successful intervention in human medicine
TBC
TBC
10:00
Successful interventions veterinary medicine
TBC
TBC
10:15
Successful interventions environment
TBC
TBC
10:30
coffee, tea
11:00
Working Groups (round 1)
Working groups led by 6 nominated working group leaders6 parallel working group discussions related to the 6 focal areas
12:30
Sandwiches, coffee, tea refreshments
13:30
Working Groups (round 2 with new composition working groups)
Working groups led by 6 nominated working group leaders6 parallel working group discussions related to the 6 focal areas
15:00
Coffee, tea
15:30
Reflection by the 6 working group leaders on results obtained (6 x 15 minutes)
6 Working group leaders
6 Working group leaders
17:00
Wrap up day 2
Prof Paul Verweij
Prof Paul Verweij
17:15
(No program)
18:30
Conference dinner
Location TBC
21 March 2024
Focus: Prioritizing and follow-up
Chair: Prof Paul Verweij, Radboud University Medical Centre, Nijmegen, The Netherlands
08:30
Coffee, tea
09:00
Prioritizing
Joint priority setting focal areas 1-6 (15 minutes per focal area)RIVM Facilitators
10:30
Coffee, tea
11:00
Critical success factors implementation roadmap
RIVM Facilitators
RIVM Facilitators
11:15
Broadening the scope to other resistant fungi
Prof Paul Verweij
Prof Paul Verweij
11:30
Roadmap structure, process and planning
Dr Maarten van Dongen, AMR Insights
Dr Maarten van Dongen, AMR Insights
11:45
Consensus declaration: idem
Dr Maarten van Dongen, AMR Insights
Dr Maarten van Dongen, AMR Insights
12:00
Publication on the AFR viewpoint
Dr Jochem Buil, Radboud University Medical Centre, Nijmegen, The Netherlands
Dr Jochem Buil, Radboud University Medical Centre, Nijmegen, The Netherlands
12:15
Publication on the roadmap
Dr Auke de Jong, National Institute for Public Health and the Environment
Dr Auke de Jong, National Institute for Public Health and the Environment
12;30
Closure
Q&A, final commentsAll
12:45
Wrap up and closing
Prof Paul Verweij, Radboud University Medical Centre, Nijmegen, The Netherlands
Prof Paul Verweij, Radboud University Medical Centre, Nijmegen, The Netherlands